The p53 tumor suppressor protein plays a critical role in the cellular response to DNA damage leading to cell cycle arrest or apoptosis depending on cell type, culture conditions, and the extent of DNA damage. Loss of the p53-dependent DNA damage response can lead to genomic instability and the survival of cells carrying mutations and carcinogenic lesions thereby contributing to malignancy (1). DNA strand breaks produced by ionizing radiation (IR) 1 or by DNA repair intermediates following treatment with UV radiation or chemotherapeutic agents result in the accumulation of p53 protein and in the activation of its transcriptional activity (reviewed in Refs. 2 and 3). Elevated levels of p53 protein are believed to be important to initiate the events that lead to G 1 arrest or apoptosis after DNA damage. There is compelling evidence that post-translational modification of p53 is required for its stabilization, as well as for activation of its latent sequence-specific DNA-binding and transactivation functions. Once p53 becomes activated it binds as a tetramer to p53 responsive elements on double stranded DNA consisting of two half-sites (5Ј-PuPuPuC(A/T)(T/A)GPyPyPy-3Ј) separated by a spacer consisting of 0 -13 nucleotides (4). The site-specific DNA-binding activity of p53 leads to transcriptional activation of p53 target genes. Covalent modification of p53 has also been shown to regulate its subcellular localization, tetramerization, interaction with other proteins, and degradation. p53 protein is modified in vivo through phosphorylation, acetylation, poly(ADP-ribosyl)ation, ubiquitination, and sumoylation reactions (reviewed in Refs. 2 and 5). The events upstream of p53 activation are complex and not well understood. Several DNA damage sensory molecules are believed to relay the DNA damage signal to p53; each may be involved in the response to one or more types of DNA damage. For example, ataxia-telangiectasia-mutated kinase protein is involved in the activation of p53 in response to IR (6, 7), and ataxia telangiectasia-related kinase protein is involved in the activation of p53 in response to UV irradiation (8).
The p53 tumor suppressor protein plays a critical role in the cellular response to DNA damage leading to cell cycle arrest or apoptosis depending on cell type, culture conditions, and the extent of DNA damage. Loss of the p53-dependent DNA damage response can lead to genomic instability and the survival of cells carrying mutations and carcinogenic lesions thereby contributing to malignancy (1) . DNA strand breaks produced by ionizing radiation (IR) 1 or by DNA repair intermediates following treatment with UV radiation or chemotherapeutic agents result in the accumulation of p53 protein and in the activation of its transcriptional activity (reviewed in Refs. 2 and 3). Elevated levels of p53 protein are believed to be important to initiate the events that lead to G 1 arrest or apoptosis after DNA damage. There is compelling evidence that post-translational modification of p53 is required for its stabilization, as well as for activation of its latent sequence-specific DNA-binding and transactivation functions. Once p53 becomes activated it binds as a tetramer to p53 responsive elements on double stranded DNA consisting of two half-sites (5Ј-PuPuPuC(A/T)(T/A)GPyPyPy-3Ј) separated by a spacer consisting of 0 -13 nucleotides (4). The site-specific DNA-binding activity of p53 leads to transcriptional activation of p53 target genes. Covalent modification of p53 has also been shown to regulate its subcellular localization, tetramerization, interaction with other proteins, and degradation. p53 protein is modified in vivo through phosphorylation, acetylation, poly(ADP-ribosyl)ation, ubiquitination, and sumoylation reactions (reviewed in Refs. 2 and 5). The events upstream of p53 activation are complex and not well understood. Several DNA damage sensory molecules are believed to relay the DNA damage signal to p53; each may be involved in the response to one or more types of DNA damage. For example, ataxia-telangiectasia-mutated kinase protein is involved in the activation of p53 in response to IR (6, 7) , and ataxia telangiectasia-related kinase protein is involved in the activation of p53 in response to UV irradiation (8) .
Poly(ADP-ribose) polymerase (PARP-1) is an abundant nuclear enzyme that binds to, and is activated by, DNA single and double strand breaks (reviewed in Refs. 9 -11) . Its activation represents one of the earliest responses to DNA damage in the cell. PARP-1 catalyzes the sequential transfer of ADP-ribose monomers onto nuclear protein acceptors using NAD ϩ as substrate. During the process of poly(ADP-ribosyl)ation, NAD ϩ is hydrolyzed and released as free nicotinamide. More than 30 nuclear proteins have been identified as poly(ADP-ribose) (pADPr) acceptors, with PARP-1 itself being the major target, via its automodification domain. pADPr acceptor proteins may be modified through covalent as well as through non-covalent association with pADPr, either free or bound to PARP-1. Poly-(ADP-ribose) glycohydrolase is the major enzyme responsible for the hydrolysis of pADPr. There is general agreement, based on genetic and biochemical studies, that PARP-1 plays a critical role in the maintenance of genomic integrity.
PARP-1 and p53 have been shown to interact in a number of cell lines including the human leukemia-derived cell line OCI/ AML-3 (12) . The oligomerization and DNA-binding domains of p53 contain copies of the recently characterized pADPr-binding site (13) . Furthermore, pADPr has been shown to interact non-covalently with p53 in vitro (14) , and p53 can be covalently poly(ADP-ribosyl)ated in vitro (15, 16) and in osteosarcoma cells undergoing spontaneous apoptosis (17) . Finally, recent studies show that poly(ADP-ribosyl)ation of p53 can interfere with its site-specific DNA-binding activity (18, 19) . The ability of PARP-1 to interact with and ADP-ribosylate p53 suggests a functional relationship between these two proteins. An intriguing model is that PARP-1 acts as a DNA damage sensor that regulates p53 function in response to DNA damage. A number of studies have investigated the role of PARP-1 in the p53 response to DNA damage. Several studies indicate that disruption of PARP function by chemical inhibition leads to suppression of p53-dependent transactivation in response to IR (12, 20, 21) . Chemical inhibition of PARP leads to loss of the G 1 checkpoint and accumulation of cells in G 2 /M following N-methyl-N-nitro-N-nitrosoguanidine treatment (22) or IR (20) . Other studies employing dominant negative PARP-1 mutants (23), and PARP-1 knockout mice (24 -27) have yielded confusing and apparently conflicting data. Studies using certain PARP-1-deficient mouse cells are confounded by the fact that these cells retain poly(ADP-ribosyl)ation activity (28, 29) . Thus, although PARP-1 plays a clear role in the maintenance of genomic integrity, the functional relationship between PARP-1 and p53 remains unclear.
Here we have disrupted PARP-1 function in human cells using two experimental strategies: chemical inhibition with the inhibitor 1,5-dihydroxyisoquinoline (IQ), and trans-dominant inhibition by overexpression of the catalytically inactive DNAbinding domain (DBD) of PARP-1. We have investigated the consequences of PARP-1 disruption on p53-dependent DNA damage response pathways in MCF-7 human breast adenocarcinoma cells and in BJ/TERT cells derived from normal human BJ fibroblasts that have been immortalized by ectopic expression of the telomerase enzyme (30) . These experiments reveal that inhibition of PARP-1 activity with IQ or with PARP-1 DBD overexpression suppresses the transactivation function of p53 and the ability of p53 to mediate G 1 arrest in response to ionizing radiation. This data supports the hypothesis that PARP-1 is a critical regulator of p53 function in response to DNA damage.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection-The BJ/TERT, BJ/TERT-DD, MCF-7, and MCF-7/p53A135V cells were grown in ␣-minimal essential medium supplemented with 10% fetal bovine serum at 37°C in a humidified 5% CO 2 atmosphere.
To generate BJ/TERT-DD cells, a 700-bp fragment encoding the C-terminal dimerization domain of p53 was cloned into the EcoRI site of pBabe-neo. The resulting plasmid pBabep53DDneo was cotransfected with pC-Ampho into 293TV cells and the resulting viral supernatants were used to infect BJ/TERT cells. The resulting BJ/TERT-DD cells were subsequently analyzed and shown to lack a p53-dependent G 1 checkpoint in response to ionizing radiation. In these cells the overexpressed C-terminal peptide complexes with wild-type p53 protein to form inactive heterotetramers (31) . MCF-7/p53A135V are MCF-7 cells that stably overexpress the temperature-sensitive p53
Val-135 allele (32) . In these cells, the p53 conformation is mutant at 37°C, and wild-type at 32°C.
For inhibition of PARP activity IQ (Sigma-RBI) was added to the cells 1 h prior to IR. The optimal IQ doses determined by immunofluorescence microscopy were 200 and 350 M for MCF-7 and BJ/TERT cells, respectively (data not shown). Twenty minutes post-IR, cells were washed with phosphate-buffered saline (PBS) without calcium and magnesium and incubated with fresh media containing IQ. IQ was dissolved in dimethyl sulfoxide (Me 2 SO) such that the final concentration of Me 2 SO to which cells were exposed did not exceed 0.5% (v/v).
Cells were irradiated in a 137
Cs Gammacell Exactor (Nordion International, Inc.) at a dose rate of ϳ1 Gy/min at room temperature. Initially, a dose of 6 Gy was employed for the MCF-7 Western blot analysis; however, we decided to use a dose of 2 Gy for future experiments with MCF-7 and BJ/TERT cells. Both these doses are sufficient to activate the p53-mediated DNA damage response; however, the extent of cell death is less following 2 Gy than 6 Gy in these cell lines (33, 34) thus allowing for a larger surviving fraction for subsequent analysis.
Transfection experiments were carried out by electroporation. Cells were washed in PBS, trypsinized, collected, and washed in ␣-minimal essential medium (without antibiotics or fetal bovine serum), and resuspended in the same media in combination with the appropriate plasmids. Cells were electroporated using a Bio-Rad gene pulser at 250 V, 950 microfarads. For the MCF-7 Western blot analysis, MCF-7 cells were transiently transfected with 10 g of pPARP6 plasmid that encodes the PARP-1 DBD (35) or the control plasmid pcDNA3 (Invitrogen) per 5 ϫ 10 6 cells. To determine the transfection efficiency, cells were transfected with 1 g of EGFP-NL, a green fluorescent protein (GFP) reporter plasmid. For the MCF-7 cell cycle analysis, 5 ϫ 10 6 cells were transiently co-transfected with 2 g of pCMVCD20, a plasmid encoding the B-cell marker CD20, and 10 g of pPARP6 or the control plasmid pcDNA3.
Preparation of Nuclear and Cytoplasmic Extracts-Cells were grown to 75% confluence and washed twice with PBS. Lysis Buffer A (300 mM sucrose, 10 mM Tris-HCl, pH 8.0, 3 mM MgCl 2 , 1 mM EDTA, 2 mM 2-mercaptoethanol, 0.03% Nonidet P-40 supplemented with Mini-Pill protease inhibitors (Roche Diagnostics)) was added and the cells were allowed to swell 7 min. Cells were centrifuged at 800 ϫ g and the cytoplasmic fraction decanted. The nuclear pellet was washed twice with lysis Buffer A. The nuclear and cytoplasmic fractions were diluted in 1ϫ loading buffer (62.5 mM Tris-Cl, pH 6.8, 10% glycerol, 2% SDS, 6 M urea, 5% ␤-mercaptoethanol (added fresh) and 1% (w/v) bromphenol blue), sonicated (3 pulses, 15 s each), and heated at 65°C for 15 min.
Activity-Western Blot Analysis-Protein extracts were resolved by gel electrophoresis on a 10% SDS-polyacrylamide gel. Gels were soaked at 37°C in 1ϫ SDS-PAGE running buffer (125 mM Tris base, 960 mM glycine, 0.5% SDS) containing 0.7 M 2-mercaptoethanol (Sigma). The proteins were transferred onto a Hybond C nitrocellulose membrane (APBiotech). After refolding of the membrane-bound proteins in renaturation buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM dithiothreitol, 0.3% Tween), the membranes were incubated in the same buffer supplemented with 2 g/ml DNase I-activated calf thymus DNA (Sigma), 2 mM Mg 2ϩ , 20 M Zn 2ϩ , and 2 Ci/ml [␣-32 P]NAD. To remove non-covalently bound pADPr, the membranes were washed in renaturation buffer until no radioactivity was detected in the washes. Covalently bound pADPr was detected by autoradiography.
Western Blot Analysis-Cells were washed with PBS, lysed with either SDS loading buffer or SUG buffer (3% SDS (w/v), 6% urea, 10% glycerol, 125 mM Tris-HCl, pH 6.8, with protease inhibitors), collected, and sonicated for 20 s. For the BJ/TERT and BJ/TERT-DD protein analyses, DNA was removed by centrifugation in a Qiashredder column (Qiagen). Protein content of the cell extracts was measured using a modified Lowry assay (Sigma). Following addition of dithiothreitol (100 mM) and bromphenol blue (1% w/v) the protein samples were denatured at 70°C for 5 min, resolved by gel electrophoresis on an SDS-polyacrylamide gradient gel, and transferred by electroblotting onto polyvinylidene difluoride membranes. Primary antibodies against p53 (PAb1801, 1:10 for MCF-7; PAb421, 1:100 for BJ/TERT and BJ/TERT-DD), p21 (1:1000; BD Pharmingen), mdm-2 (2A10, 1:1000), ␤-actin (1:1000; Sigma), and PARP-1 (C2-10, 1:10,000) were used in conjunction with horseradish peroxidase-conjugated anti-mouse (1:2500; Sigma) or antisheep secondary antibodies (1:5000; Cedarlane) and the blot visualized using the Renaissance ECL detection system (PerkinElmer Life Sciences). For the BJ/TERT and BJ/TERT-DD blots, Coomassie Blue stain was used to determine equal loading of protein.
Northern Blot Analysis-Total RNA was isolated from BJ/TERT and MCF-7 cells using a modified guanidine isothiocyanate method (Trizol, Invitrogen) according to the manufacturer's instructions. RNA content was measured by A 260 . Twelve g of each RNA sample was separated on a 1% denaturing agarose gel and transferred to Hybond N ϩ membrane (APBiotech). The blot was hybridized with 32 P-radiolabeled cDNA probes to p21 and GAPDH. Following standard washes, phosphorimage analysis was carried out, and RNA quantitated using ImageQuant software (Amersham Biosciences).
Cell Cycle Analysis-To assess the G 1 arrest response in MCF-7 and BJ/TERT cells, asynchronously dividing cells were plated on 150-mm tissue culture dishes (MCF-7 at 1 ϫ 10 6 cells, BJ/TERT at 5 ϫ 10 5 cells).
Following overnight incubation at 37°C, cells were treated with IQ (MCF-7 at 200 M, BJ/TERT at 350 M) and 1 h later irradiated at 2 Gy. Cell cycle distribution was examined by flow cytometry using the propidium iodide (PI) DNA staining method. BJ/TERT and BJ/TERT-DD cells were washed once with PBS and incubated on ice in 0.1% sodium citrate, 0.2% Nonidet P-40, and 50 g/ml PI to release nuclei. Cells were collected and nuclei were analyzed for DNA content by flow cytometry. For the time course analysis, BJ/TERT cells were washed once with PBS and incubated with PBS containing 0.5% EDTA for 10 min. Cells were scraped into ␣-minimal essential medium and collected by centrifugation. Following one wash in cold PBS, cells were fixed with 75% ethanol overnight at 4°C. Cells were washed in PBS containing 0.5% bovine serum albumin, and resuspended in the same buffer containing 50 g/ml PI (from 5 mg/ml stock in 38 mM sodium citrate, pH 7.4), and 200 g/ml RNase A. After incubation for 30 min at 37°C, cells were analyzed for DNA content by flow cytometry. MCF-7 and MCF-7/p53A135V cells were prepared for flow cytometry as described for the BJ/TERT time course.
For analysis of transient overexpression of the PARP-1 DBD, MCF-7 cells were transfected as described previously. Transfected cells were plated on 150-mm tissue culture dishes and incubated at 37°C. Cells were irradiated 38 h post-transfection, and 16 h later, prepared for flow cytometric analysis with the following modifications: cells were stained with a fluorescein isothiocyanate-conjugated anti-CD20 antibody (BD Pharmingen) for 30 min at 4°C prior to ethanol fixation, and 10 g/ml PI was used. Both CD20ϩ and CD20Ϫ cells were analyzed for DNA content.
Cell cycle distribution was determined with a FACSCalibur flow cytometer (BD Biosciences) using CellQuest software (BD Biosciences). The relative proportion of cells in each phase of the cell cycle was determined using ModFit LT 2.0 software (Verity Software House Inc.).
RESULTS

Human MCF-7 and BJ/TERT Cells Express a Single Species with NAD-and DNA-dependent PARP Activity Corresponding to PARP-1-
The recent demonstration that mouse cells express at least two proteins with DNA-dependent PARP activity prompted us to examine PARP activity in human MCF-7 and BJ/TERT cells using an in situ based activity assay. ActivityWestern blots were performed with nuclear and cytoplasmic extracts equivalent to 100,000 BJ/TERT and MCF-7 cells. Purified bovine PARP-1 was included as a positive control. It has been previously shown that normal mouse embryo fibroblasts have two active poly(ADP-ribosyl)ating species; a major active band corresponding to the 113-kDa PARP-1 and a second active band with an approximate molecular mass of 60 kDa corresponding to sPARP-1 (29) . In contrast, the human cell lines BJ/TERT and MCF-7 express only one protein species capable of NAD ϩ -dependent self-poly(ADP-ribosyl)ation in the presence of DNA strand breaks, provided by the DNase I-activated calf thymus DNA (Fig. 1A) . This protein is present predominantly in the nuclear fraction and corresponds to PARP-1. NAD ϩ -dependent self-poly(ADP-ribosyl)ation of PARP-1 is also observed in the activity blot performed without DNase I-activated calf thymus DNA (Fig. 1B ), but to a significantly lesser extent, confirming that PARP-1 poly(ADP-ribosyl)ation activity is activated by DNA strand breaks.
Disruption of PARP by Chemical Inhibition Suppresses p21 and mdm-2 Protein Induction following Ionizing Radiation-
Chemical inhibition of PARP activity with specific inhibitors, such as IQ and 3-aminobenzamide, has been shown to suppress p53-dependent induction of p21 following DNA damage in several cell lines, including the human leukemia-derived OCI/ AML-3 cell line (12) . To investigate the consequences of PARP inhibition on the MCF-7 and BJ/TERT cell lines, these cells were treated with IQ (MCF-7 at 200 M, BJ/TERT at 350 M) for 1 h, ␥-irradiated (MCF-7 at 6 Gy, BJ/TERT at 2 Gy), and a Western blot time course carried out at the indicated times (Fig. 2, A, left and right panels, and B) . Following IR, cells not treated with IQ showed induction of both p21 and mdm-2, as expected. Prior treatment with the chemical inhibitor IQ resulted in a delay in the kinetics of induction of both proteins and to a suppression of mdm-2 and p21 protein accumulation. Most dramatic was the almost complete lack of p21 accumulation in BJ/TERT. Equal loading was confirmed by subsequent immunoblotting of the membranes with an antibody to actin (MCF-7) or by staining with Coomassie Blue (BJ/TERT and BJ/TERT-DD, data not shown). BJ/TERT and MCF-7 cells treated with IQ showed increased basal levels of both p53 and p21. p53 protein induction following IR was comparable in both the control and IQ-treated BJ/TERT cells although the accumulation of p53 was prolonged in the presence of IQ. In MCF-7 cells treated with IQ, we did not observe induction of p53 beyond the elevated basal level. BJ/TERT-DD cells express the C-terminal fragment of p53. This fragment has been shown to act as a potent trans-dominant repressor of wild type p53 through its ability to prevent the formation of functional p53 tetramers (31) . Endogenous p53 levels are high in these cells likely resulting from the formation of stable heterologous oligomers with the abundant C-terminal peptides. BJ/TERT-DD cells fail to induce p21 or mdm-2 in response to IR providing confirmation that the induction of p21 and mdm-2 in BJ/TERT cells is dependent on functional p53 (Fig. 2C) .
Disruption of PARP by Chemical Inhibition Suppresses Transcription of p21 mRNA following Ionizing Radiation-The p53-dependent elevation of p21 protein levels in response to ionizing radiation is controlled at the transcriptional level. We wished to investigate whether PARP inhibition with IQ interfered with the transactivation function of p53. BJ/TERT and MCF-7 cells were treated with 350 or 200 M IQ and ␥-irradiated with 2 or 6 Gy, respectively. Total RNA was prepared at the indicated times and Northern blot analysis was performed using radiolabel led p21 and GAPDH cDNA probes (Fig. 3, top  panel) . Following normalization to GAPDH, RNA levels were quantitated and plotted (Fig. 3, bottom panel) . In non-treated MCF-7 cells, p21 mRNA levels were induced by 2 h following IR, and remained elevated at subsequent time points. In MCF-7 cells treated with IQ, the induction of p21 mRNA following IR was delayed by 1.5 to 2 h compared with non-treated cells, an effect similar to that observed at the protein level ( Fig.  2A) . BJ/TERT cells showed a more dramatic effect: prior treatment with IQ led to almost complete suppression of p21 mRNA induction at all time points. These results indicate that IQ suppresses induction of p21 expression in response to IR by interfering with the transactivation function of p53. FIG. 1. PARP-1 is the only detectable species capable of selfpoly(ADP-ribosyl)ation in BJ/TERT and MCF-7 cells. Cytoplasmic and nuclear extracts equivalent to 100,000 BJ/TERT and MCF-7 cells were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. Following incubation in renaturation buffer to refold proteins, membranes were incubated in buffer containing 32 P-labeled NAD ϩ , with (A) or without (B) DNase I-activated calf thymus DNA for 1 h. The membranes were subsequently washed in renaturation buffer to remove noncovalently bound pADPr and exposed to autoradiography film to detect poly(ADP-ribosyl)ated proteins. Purified recombinant PARP-1 (100 milliunits) was included as a positive control.
Disruption of PARP by Chemical Inhibition Suppresses the p53-mediated G 1 Arrest
Response following Ionizing Radiation-p21 is a critical effector of the p53-mediated G 1 arrest response following DNA damage. Both MCF-7 cells and BJ/ TERT cells undergo G 1 arrest in response to low doses of ionizing radiation (33, 34) . Our result showing that PARP inhibition suppresses p53-mediated transactivation of p21 indicates that PARP inhibition should lead to disruption of the p53-dependent G 1 checkpoint. To test this possibility, cell cycle analysis using PI to assess DNA content was performed.
BJ/TERT and BJ/TERT-DD cells were treated with 350 M IQ, ␥-irradiated at 2 Gy, and 24 h later cell cycle analyses were performed by flow cytometry. The proportion of cells in each phase of the cell cycle was determined in three (BJ/TERT-DD) or six (BJ/TERT) independent experiments and the mean values summarized (Fig. 4A, top panel) . Also shown are the G 1 /S ratios (Fig. 4A, bottom panel) . In addition to G 1 arrest, ionizing radiation can lead to arrest in G 2 , and this block can result in a decrease in the proportion of cells in the G 1 and S phases of the cell cycle. For this reason, it is important to compare the G 1 /S ratios; an increase in the G 1 /S ratio following DNA damage has been used as an indicator of G 1 arrest. BJ/TERT cells showed a significant increase (6.7-fold) in the G 1 /S ratio following IR, indicating that these cells were undergoing G 1 arrest. In contrast, BJ/TERT-DD cells showed no increase in the G 1 /S ratio after IR confirming that G 1 arrest is dependent on p53. Importantly, BJ/TERT cells treated with IQ showed a marked decrease in p53-mediated G 1 arrest. We confirmed this observation by performing a time course experiment. BJ/TERT cells were treated with 350 M IQ or Me 2 SO and ␥-irradiated at 2 Gy. Flow cytometric analysis of cells was performed to determine the cell cycle profiles at various time points for both non-treated cells (Fig. 5A ) and cells treated with IQ (Fig. 5B) . The percentage of cells in each cell cycle phase and G 1 /S ratios were determined. The mean Ϯ S.E. are shown for three independent experiments (Table I) . BJ/TERT cells showed a strong G 1 arrest response by 13 h post-IR and cells remained in a G 1 -arrested state at later time points. In contrast, IQ treatment of BJ/TERT cells delayed and attenuated this G 1 arrest response.
We also investigated the effect of IQ on the p53-mediated G 1 checkpoint in MCF-7 cells and in MCF-7 cells expressing a dominant negative p53 allele (p53A135V). Cells were treated with 200 M IQ, ␥-irradiated at 2 Gy, and 16 h later the cell cycle profiles were analyzed by flow cytometry (Fig. 4B, top  panel) . The 16-h time point was chosen based on our previous observation that G 1 arrest can be observed in asynchronous MCF-7 cell cultures 12 to 20 h following IR at 2 Gy (data not shown). Also shown are the G 1 /S ratios (Fig. 4B, bottom panel) . MCF-7 cells showed a 5.2-fold increase in the G 1 /S ratio after for 1 h and ␥-irradiated at 2 Gy. Cells were collected at the appropriate time points, fixed in 75% ethanol overnight at 4°C, and stained with PI (50 g/ml in 38 mM sodium citrate, pH 7.4). DNA content was measured with a FACSCalibur flow cytometer and cell cycle profiles were generated using CellQuest software.
TABLE I Effects of chemical inhibition of PARP on cell cycle distribution of BJ/TERT cells following ␥-irradiation
The percentage of cells in each cell cycle phase and G 1 /S ratios were determined for the BJ/TERT analysis shown in Fig. 5 using ModFit LT 2.0 software. The mean Ϯ S.E. are shown for three independent experiments.
Time
Me 2 SO IQ poly(ADP-ribosyl)ation of nuclear proteins was observed even though PARP-1 DBD was abundantly expressed (data not shown). Retention of PARP activity is not the result of compensatory PARP enzymes such as sPARP-1, observed in PARP-1 Ϫ/Ϫ mouse embryo fibroblasts (29) , because PARP-1 is the only NAD-dependent poly(ADP-ribosyl)ating enzyme detected in BJ/TERT cells. Rather, it may be the result of insufficient DBD expression in the clones. It is also possible that PARP-1 activity is required for long-term survival of the BJ/TERT cells. As a result, we employed transient expression assays. The plasmid pPARP-6 has been used effectively in transient expression analyses to inhibit PARP function (35, 36) . The transfection efficiency of BJ/TERT is extremely low and we were unable to achieve sufficient transient expression of PARP-1 DBD in these cells. We turned to MCF-7 cells that have higher transfection efficiency. Cells were transfected at an efficiency of ϳ31%. Forty-eight hours post-transfection with pPARP6, cells were ␥-irradiated at 6 Gy, as with the MCF-7 Western blot time course previously described, and protein extracts were prepared from the entire cell population (transfected and non-transfected) at the indicated times and analyzed by Western blotting (Fig. 6) . The PARP-1 DBD was expressed only in those cells transfected with pPARP6, and not in cells transfected with the control vector pcDNA3. Notably, p21 basal levels were increased, and the induction of p21 protein following IR was delayed and attenuated in cells expressing the PARP-1 DBD.
Disruption of PARP-1 by Trans-dominant Inhibition Suppresses the p53-mediated G 1 Checkpoint following Ionizing Radiation-We wished to determine whether PARP-1 DBD overexpression abrogates the p53-dependent G 1 checkpoint in MCF-7 cells. pPARP6 or empty vector (pcDNA3) were co-transfected with the pCMVCD20 expression vector encoding the B cell surface marker CD20. Cells were irradiated at 2 Gy 38 h after transfection. Sixteen hours after IR, transfected cells were identified by CD20 staining, and the cell cycle profiles of the CD20-positive and CD20-negative cell populations were determined by flow cytometry (Fig. 7, A and B, top panel) . The latter represent cells that were not successfully transfected and hence, serve as additional controls in these experiments. The CD20-negative populations from both the pcDNA3 co-transfection and the pPARP6 co-transfection exhibited G 1 arrest following IR reflected by the increases in the G 1 /S ratio (9.5-fold, and 8-fold, respectively) (Fig. 7A, bottom panel) . The CD20ϩ cells transfected with pcDNA3 showed a 7-fold increase in the G 1 /S ratio following IR (Fig. 7B, bottom panel) . This is comparable with the CD20-negative cells and is indicative of arrest in G 1 . In contrast, CD20-positive cells co-transfected with the dominant-negative pPARP6, exhibited only a 2.2-fold increase in the G 1 /S ratio indicating a significant suppression of the G 1 checkpoint.
DISCUSSION
Following DNA damage induced by ionizing radiation and alkylating agents, the nuclear enzyme PARP-1 is activated leading to rapid and transient poly(ADP-ribosyl)ation of nuclear proteins (37) . Studies of PARP-1 knockout mice indicate a critical role for PARP-1 in the maintenance of genomic integrity (reviewed in Refs. 10 and 11); however, the molecular mechanisms through which PARP-1 functions in the cellular response to genotoxic stress and in DNA repair are not fully understood. Several studies suggest an indirect role for PARP-1 in base excision repair. In response to DNA damage, PARP-1 is recruited to strand breaks where it may act as a "nick protector" at sites of DNA damage to facilitate repair (38, 39) . PARP-1-interacting proteins may also be recruited to DNA strand breaks to participate in the repair process. Poly(ADPribosyl)ation of histones may serve to open up chromatin following DNA damage, to allow access to DNA repair enzymes (40) .
The p53 tumor suppressor also plays a critical role in the cellular response to DNA damage. In cells that have been exposed to genotoxic stresses such as ionizing radiation, UV irradiation, or alkylation, p53 activates transcription of target genes that are involved in either cell cycle arrest or apoptosis. These responses ensure that permanent mutations are not created, and that genetic integrity is maintained (1, 41) .
We have previously shown that p53 protein can bind to PARP-1 in the human leukemia-derived OCI/AML-3 cell line. In the same study, we also demonstrated that analogs of NAD ϩ that selectively inhibit endogenous poly(ADP-ribosyl)ation are able to overcome p53-dependent senescence in early passage human fibroblasts (12) . Other studies have shown that p53 can be poly(ADP-ribosyl)ated in vivo (17) and in vitro (15, 16, 18) . In the present work, we have investigated the functional relationship between PARP-1 and p53. Using two experimental strategies to inhibit PARP-1 function, we have observed an attenuation of the activity of the p53 protein as a transcription factor at the p21 promoter in two human cell types. These cell types exhibit a p53-dependent arrest in the G 1 phase of the cell cycle following ionizing radiation. We observed that inhibition of PARP-1 activity caused a marked disruption of p53-mediated G 1 arrest following ionizing radiation. These results demonstrate a critical role for PARP-1 in the p53-dependent G 1 checkpoint. Although inhibition of PARP-1 by IQ treatment led to comparable effects on p53 transactivation function in BJ/TERT and MCF-7 cells, it had different effects on p53 induction and accumulation. The induction of p53 protein in irradiated BJ/ TERT cells was unaffected by IQ. In contrast, MCF-7 cells treated with IQ did not show p53 induction beyond the basal level following irradiation.
Recent studies indicate the existence of a family of PARP enzymes that catalyze NAD-dependent poly(ADP-ribosyl)ation. These include tankyrase-1 (42), tankyrase 2 (43), and VPARP (44) , enzymes that are not activated by DNA strand breaks. Another family member, PARP-2, has been shown to bind to and be activated by DNA strand breaks, although this protein lacks the classical zinc finger DNA-binding domain of PARP-1 (45) . Finally, sPARP-1, although lacking a DNA-binding domain, can be activated by DNA damage (29) . In this study, we have only been able to detect one NAD-dependent ADP-ribosyltransferase species capable of self-poly(ADP-ribosyl)ation in BJ/TERT and MCF-7 cells, namely PARP-1. This finding lessens the possibility that another PARP family member is acting upstream of p53 in response to DNA damage.
Trans-dominant inhibition of PARP-1 led to a G 2 delay in both non-treated and ␥-irradiated MCF-7 cells, suggesting that PARP-1 may be involved in G 2 /M progression. A similar effect was observed in MCF-7 and BJ/TERT cells treated with IQ, in agreement with previous studies using the chemical inhibitor 3-aminobenzamide (20, 46) ; however, the G 2 delay was more pronounced in these cells as compared with those overexpressing the PARP-1 DBD. These results suggest that chemical inhibition by IQ may lead to PARP-1-independent effects on the G 2 /M transition.
The effects of IQ treatment on the p53 response to IR observed in this study are consistent with previous inhibitor studies (12, 20, 21, 46) ; however, the use of NAD analogs to inhibit PARP activity can be criticized because of the possibility of nonspecific effects on other NAD-dependent processes, for example, those that require mono(ADP-ribosyl) transferases (47) . In this study, trans-dominant inhibition of PARP-1 by PARP-1 DBD overexpression led to disruption of p21 induction and suppression of p53-mediated G 1 arrest in MCF-7 cells. These results confirm that chemical inhibition of PARP by IQ disrupts the p53-mediated G 1 checkpoint in MCF-7 cells by interference with PARP-1 activity.
Recent studies indicate an involvement of PARP-1 in transcriptional regulation. Various reports indicate that PARP-1 can either promote or repress transcription. Interestingly, this activity of PARP-1 requires the DNA binding but not the catalytic function of PARP-1 (reviewed in Ref. 48 ). Hence, PARP-1 DBD expression may affect gene expression in addition to inhibiting the enzymatic activity of PARP-1. This caveat emphasizes the importance of using different but complementary strategies to inhibit PARP-1 function. During the course of these experiments, we observed an elevated basal level of p53 and p21 protein in IQ-treated BJ/TERT and MCF-7 cells, and in DBD-expressing MCF-7 cells. p21 mRNA levels are not elevated in IQ-treated cells suggesting that this change in basal expression is controlled post-transcriptionally. We are currently investigating this further. In the context of DNA damage a possible novel regulatory function of the DBD would presumably not affect the transcription of DNA damage response genes because DNA damage would lead to preferential binding of the DBD to DNA strand breaks, relieving any ability to modulate transcription.
The precise mechanism through which PARP-1 positively regulates p53 activity remains to be determined. One possibility is covalent poly(ADP-ribosyl)ation of p53. Poly(ADPribosyl)ation of p53 has been observed in vivo in osteosarcoma cells undergoing spontaneous apoptosis (17, 49) . To date there has been no report of poly(ADP-ribosyl)ation of p53 following DNA damage. Another possibility is that p53 interacts noncovalently with pADPr, either free or bound to nuclear protein acceptors such as PARP-1. Three regions within the tetramerization and DNA-binding domains have been found to interact with pADPr in vitro (14) ; these regions contain putative pADPr-binding sites as determined by sequence alignment analysis (13) . It remains to be determined whether these regions interact non-covalently with pADPr in vivo. Covalent or non-covalent modification might serve to modulate the sitespecific DNA-binding activity of p53 or its transcriptional activity (18, 19) . Finally, PARP-1 activity may regulate other post-translational modifications of p53 such as phosphorylation or acetylation, in response to DNA damage. In summary, using two different strategies to disrupt PARP-1 function, we have established that PARP-1 is a positive regulator of p53 transactivation function in response to ionizing radiation in both the transformed cell line, MCF-7, and the non-transformed cell line, BJ/TERT. The precise mechanism through which PARP-1 positively regulates the p53-mediated DNA damage response remains to be determined.
